Many factors affect the low numbers of insured among Generation Y.
WellPoint, Inc. announced Martin Silverstein, M.D., has been named chief strategy officer, effective April 28th.
According to a release, Dr. Silverstein will oversee WellPoint's enterprise marketing, corporate development and strategy functions, and will be responsible for short and long-term strategic planning to ensure the Company is maximizing the value of its assets and capturing growth across its geographies and businesses.
"Marty brings broad health care sector expertise to the role, and is respected throughout the industry for advancing innovative business solutions at the intersection of managed care, care delivery, pharmacy, and health care reform," said Joseph R. Swedish, WellPoint's CEO. "His leadership and experience will be critical as we refine and advance our strategies to further our position as a valued health partner and leading health benefits company."
Dr. Silverstein joins WellPoint from The Boston Consulting Group (BCG) where he was a Senior Partner and Managing Director. In his more than twenty-five years at BCG, Dr. Silverstein has held many leadership roles from establishing its U.S. Payers and Providers sector and having led the firm's Global Health Care Practice. He has consulted to clients in most sectors of the health care industry, including managed care organizations, integrated delivery and hospital systems, biopharmaceutical manufacturers, and retail pharmacies. Before joining BCG he worked as a physician in private and corporate practice and as a senior scientist and project manager at the Health Data Institute.
WellPoint is a health benefits company.
((Comments on this story may be sent to firstname.lastname@example.org))